Owlstone Medical

Owlstone Medical is an innovative healthcare technology company specializing in biomarker research, development, and breath testing. This UK-based organization has garnered remarkable attention for its groundbreaking Breath Biopsy technology product. The company's core mission is to utilise breath testing in order to save 100,000 lives and reduce healthcare costs by $1.5B. Their vision is to become a leading figure worldwide in Breath Biopsy for early detection of diseases and precision medicine.

The science and technology branch of the company focuses on various aspects such as Respiratory Droplets, FAI MS Technology, VOC Biomarkers, and EVOC Probes. It also explores and develops research products and services, notably the Breath Biopsy Collection Station and Breath Biopsy OMNI, cutting-edge tools for reliable and comprehensive breath biomarker analysis. In addition to this, the firm also ventures into the healthcare industry with products designed to diagnose and monitor cardiometabolic and respiratory diseases. The company's robust R&D team is committed to bringing Volatile Organic Compound (VOC) biomarker research to labs everywhere.

Owlstone Medical evidently holds a strong market position, backed by its progressive scientific discoveries and healthcare solutions. Investing or partnering with Owlstone Medical offers significant value and potential for pioneering research, innovative product development, and societal impact via their life-saving technology. With a global presence and a determined mission to contribute significantly to the healthcare industry, the company presents a compelling interest for anyone engaged in the sectors of biomedical research, health tech innovations, and precision medicine.

Connect